Marc Ullman, Esq.
Rivkin Radler LLP
Marc Ullman is of counsel to Rivkin Radler LLP and a partner with Ullman, Shapiro & Ullman LLP. His practice focuses on FDA compliance—such as labeling, claims and GMPs (good manufacturing practices)—as well as GMP-related challenges including responses to FDA 483s and warning letters. He has represented clients in adversarial proceedings relating to the scope of FDA's powers and its ability to seek consumer restitution. Ullman successfully guided self-GRAS (generally recognized as safe) review for stevia, allowing his client to legally import the herb, and he’s assisted clients with the new dietary ingredient (NDI) process for dietary supplements.
What Is the Regulatory Current State of Play With CBD?